Sylvie Schmidt
Strasbourg, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Deciphering HIV vaccine-induced antibody response according to ethnicity.
Journal: AIDS (London, England)
Published: October 21, 2024
Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains.
Journal: AIDS (London, England)
Published: August 24, 2022
Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity.
Journal: International journal of biological macromolecules
Published: July 28, 2022
Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies.
Journal: Frontiers in medicine
Published: June 19, 2022
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.
Journal: Science translational medicine
Published: October 26, 2021
Distinct antibody profiles in HLA-B∗57+, HLA-B∗57- HIV controllers and chronic progressors.
Journal: AIDS (London, England)
Published: September 28, 2021
Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors.
Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors.
Journal: Journal of molecular biology
Published: June 17, 2020
NKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases.
Journal: Journal of virology
Published: May 26, 2020
A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome.
Journal: Genes and immunity
Published: March 25, 2020
Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins.
Journal: Journal of molecular biology
Published: April 12, 2019
HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
Journal: AIDS (London, England)
Published: April 24, 2018
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.
Journal: Scientific reports
Published: June 09, 2017
Last Updated: 09/26/2026